le 4 mai/May 2023

	The common shares of MindBio Therapeutics Corp. have been approved for listing on the CSE.

	Listing and disclosure documents will be available at&nbsp;<a href="https://thecse.com/en/listings/life-sciences/mindbio-therapeutics-corp">www.thecse.com</a>&nbsp;on the trading date.

	MindBio Therapeutics Corp.,&nbsp;through its wholly owned subsidiaries, MindBio Therapeutics Pty. Ltd. and Digital Mind Technology Pty Ltd., operates as a biotechnology company focused on creating novel and emerging treatments for mental health conditions. The Company has a notable presence in microdosing of psychedelic medicines and is advancing its drug and technology intervention protocols through clinical trials. The Company invests in research that forms the basis for developing novel and clinically proven treatments including digital technologies and interventions to treat debilitating health conditions such as depression, anxiety and other related mental health conditions.

	__________________________

	Les actions ordinaires de MindBio Therapeutics Corp. ont été approuvées pour être cotées sur le CSE.

	Les documents d'inscription et d'information seront disponibles sur <a href="https://thecse.com/fr/inscriptions/sciences-biologiques/mindbio-therapeutics-corp">www.thecse.com</a> à la date de négociation.

	MindBio Therapeutics Corp., par l'intermédiaire de ses filiales en propriété exclusive, MindBio Therapeutics Pty. Ltd. et Digital Mind Technology Pty Ltd., opère en tant que société de biotechnologie axée sur la création de traitements nouveaux et émergents pour les problèmes de santé mentale. La société a une présence notable dans le microdosage des médicaments psychédéliques et fait progresser ses protocoles d'intervention médicamenteux et technologiques par le biais d'essais cliniques. La Société investit dans la recherche qui constitue la base du développement de traitements nouveaux et éprouvés en clinique, y compris des technologies numériques et des interventions pour traiter des problèmes de santé débilitants tels que la dépression, l'anxiété et d'autres problèmes de santé mentale connexes.
<table border="1" cellpadding="1" cellspacing="1" >
<tbody>
<tr>
<td >
				Issuer/Émetteur:</td>
<td >
				MindBio Therapeutics Corp.</td>
</tr>
<tr>
<td >
				Security Type/Titre:</td>
<td >
				Common&nbsp;Shares/Actions&nbsp;ordinaires</td>
</tr>
<tr>
<td >
				Symbol(s)/Symbole(s):</td>
<td >
				MBIO</td>
</tr>
<tr>
<td >
				Number of securities issued and outstanding/&nbsp;Titres&nbsp;émis&nbsp;et en circulation:</td>
<td >
				133 047 305</td>
</tr>
<tr>
<td >
				Number of Securities reserved for issuance/&nbsp;Titres&nbsp;réservés&nbsp;pour&nbsp;émission:</td>
<td >
				38 669 449</td>
</tr>
<tr>
<td >
				CSE Sector/Catégorie:</td>
<td >
				Life Sciences/Sciences biologiques</td>
</tr>
<tr>
<td >
				CUSIP:</td>
<td >
				60256C 10 8</td>
</tr>
<tr>
<td >
				ISIN:</td>
<td >
				CA 60256C 10 8 6</td>
</tr>
<tr>
<td >
				Boardlot/Quotité:</td>
<td >
				1000</td>
</tr>
<tr>
<td >
				Trading&nbsp;Currency/Monnaie&nbsp;de&nbsp;négociation:</td>
<td >
				CDN$/$CDN</td>
</tr>
<tr>
<td >
				Listing Date/Date de l’inscription:</td>
<td >
				le 5 mai/May&nbsp;2023</td>
</tr>
<tr>
<td >
				Other Exchanges/Autres&nbsp;marches:</td>
<td >
				N/A</td>
</tr>
<tr>
<td >
				Fiscal Year&nbsp;end /Clôture&nbsp;de&nbsp;l'exercice&nbsp;financier:</td>
<td >
				le 30 June/juin</td>
</tr>
<tr>
<td >
				Transfer Agent/Agent des&nbsp;transferts:</td>
<td >
				Odyssey Trust Company</td>
</tr>
</tbody>
</table>

	The Exchange is accepting Market Maker applications for MBIO. Please email:&nbsp;<a href="mailto:Trading@theCSE.com">Trading@theCSE.com</a>

	If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail:&nbsp;<a href="mailto:Listings@thecse.com">Listings@thecse.com</a>

	Pour&nbsp;toute&nbsp;question, pour&nbsp;obtenir&nbsp;de&nbsp;l’information&nbsp;supplémentaire&nbsp;veuillez&nbsp;communiquer&nbsp;avec&nbsp;le service des inscriptions au 416 367-7340 ou par&nbsp;courriel&nbsp;à&nbsp;l’adresse:&nbsp;<a href="mailto:Listings@thecse.com">Listings@thecse.com&nbsp;</a>

MindBio Therapeutics Corp.

2023-0505 - New Listing - MindBio Therapeutics Corp. (MBIO)

CSE25™

CSE Composite Index®

In this series, we delve deep into the experiences of CSE listed companies, exploring their past successes and future opportunities.

CSE Issuer Spotlight

**Follow us** for the **latest news** from the CSE

 The CSE provides a modern and efficient alternative for companies looking to access the Canadian public capital markets.

The Canadian Securities Exchange (CSE)

Learn how we streamline issuer regulation through enhanced disclosure, practical and effective regulatory oversight, and modern technology.

Listing on the CSE

Learn more about the companies we list and how to get started trading on the CSE.

Investing in Listed Companies

Learn how we lower costs, reduce complexity, and provide market making opportunities for the dealer community.

Trading on the CSE

Whether you’re an investor, business leader, or simply looking to learn more, start your journey with the CSE here.

Get Started

From announcements and market updates to in-depth interviews with company leaders - stay informed with the latest from the CSE.

Latest from the CSE

Discover newly listed companies on the CSE through our series of bite-sized interviews with company leaders.

Get to know our latest listings

Listed Company News

Market Activity

List with the CSE

Find a home for your next big idea.

Frequently Asked Questions

How does being listed on the CSE affect me as a shareholder?

Where do I get information and trade CSE listed securities?

Where can I find an RSS feed for listed company news?

Where is the CSE recognized?

Upcoming Events

join the list

Join our mailing list to receive buy-in notifications

The CSE provides a superior exchange experience by investing in our customers’ success with innovation, dedication, and passion.

Where innovation, passion, and trust intersect

We strive to be the most innovative exchange in Canada. We aim to offer unlimited global access and a customized client-centric experience while delivering the lowest cost of public capital. 

We are Canada's entrepreneurial exchange

The most searched CSE listed companies on thecse.com

Recent Quotes

Get the latest regulatory announcements from the CSE concerning its Listings Policies, Trading Rules and functionality and other important industry developments.

Notices

Get the latest information about new CSE listings, the appointment of Market Makers, market events, and other news.

Bulletins

Stay informed with CSE listed company news, providing transparency and accountability to shareholders and the public.

Company News

Stay Informed

The **total volume** traded on the CSE today is

Connect with our professionals and listing experts at industry events and conferences.